Status:

COMPLETED

Treadmill with TENS on Functional Capacity &muscle Oxygenation in PAD Patients

Lead Sponsor:

Cairo University

Conditions:

Peripheral Arterial Disease

Eligibility:

All Genders

40-75 years

Phase:

NA

Brief Summary

Fifty patients from both sexes with PAD, stage II fontaine will participate in this study. Their ages will be from 40-75 years old. They will be selected from kasr el ainy (faculty of medicine), Cairo...

Detailed Description

Procedures of the study: a) Evaluating procedures: It will be performed before treatment and 12 weeks after treatment program. History and physical examination: Complete history taking will be cond...

Eligibility Criteria

Inclusion

  • • Fifty patients who had intermittent claudication secondary to PAD
  • Ambulation during a graded treadmill test limited by leg pain consistent with intermittent claudication (stage II of the Fontaine classification of PAD)
  • Ankle-brachial index (ABI) of 0.90 or lower at rest or 0.73 or lower after exercise
  • Their age will be ranged from 40-75 years old
  • Body mass index (BMI) from 18.5 to 40 kg/m2
  • they are able to take part in an outpatient rehabilitation program
  • they are clinically stable
  • they are sedentary activity level according to Global Physical Activity Questionnaire (GPAQ).
  • smokers

Exclusion

  • • Absence of PAD
  • Inability to obtain an ABI measure because of non compressible vessels
  • Asymptomatic PAD determined from the medical history and verified during the graded treadmill test
  • Use of cilostazol and pentoxifylline initiated within 3 months before the investigation
  • Exercise tolerance limited by factors other than leg pain
  • Active cancer, renal disease, or liver disease
  • The presence of a contraindication to the use of TENS, such as a pacemaker or skin lesion.
  • walking disorders related to orthopedic or neuromuscular disease
  • myopathy
  • associated progressive disease causing deterioration in general health
  • implanted pacemaker or defibrillator
  • uncontrolled diabetes

Key Trial Info

Start Date :

October 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2024

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT06061211

Start Date

October 1 2023

End Date

November 30 2024

Last Update

December 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of physical therapy, cairo university

Cairo, Egypt